• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

18氟氟化钠骨PET在年轻背痛患者中的早期应用经验。

Early experience with fluorine-18 sodium fluoride bone PET in young patients with back pain.

作者信息

Lim Ruth, Fahey Frederic H, Drubach Laura A, Connolly Leonard P, Treves S Ted

机构信息

Division of Nuclear Medicine, Department of Radiology, Children's Hospital Boston, Harvard Medical School, Boston, MA 02115, USA.

出版信息

J Pediatr Orthop. 2007 Apr-May;27(3):277-82. doi: 10.1097/BPO.0b013e31803409ba.

DOI:10.1097/BPO.0b013e31803409ba
PMID:17414009
Abstract

PURPOSE

Skeletal positron emission tomography (PET) with fluorine-18 (18F) sodium fluoride (18F NaF) is an alternative to technetium-99m (99mTc)methylene diphosphonate (MDP) scintigraphy. Experience with pediatric PET is sparse, primarily in oncology. This study assesses the role of 18F NaF in evaluating young patients with back pain.

METHODS

Ninety-four 18F NaF PET scans were performed in 94 patients (27 males, 67 females; mean age, 15 years; range, 4-26 years) with back pain. Three-dimensional PET acquisition was performed 30 minutes after administration of 18F NaF (2.1 MBq/kg; maximum, 148 MBq). Radiation doses are presented for 18F NaF and 99mTc MDP.

RESULTS

18F NaF PET revealed a possible cause of back pain in 55% (52/94). Fifteen patients had 2 or more potential sources of back pain. Diagnoses by PET were pars interarticularis/pedicle stress (34%), spinous process injury (16%), vertebral body ring apophyseal injury (14%), stress at a transitional vertebra-sacral articulation (7%), and sacroiliac joint inflammation/stress (3%). Comparing 18F NaF PET with 99mTc MDP scintigraphy, time between injection and scanning was shorter (0.5 hours vs 3 hours), radiation dosimetry was similar (3.5 mGy vs 2.8 mGy effective dose for a 55-kg patient for 18F NaF and 99mTc MDP, respectively), and cost of radiopharmaceutical was higher.

CONCLUSIONS

18F NaF bone PET can detect a variety of skeletal abnormalities in young patients with back pain. Relative to 99mTc MDP, images are of higher resolution. Total time from tracer administration to completion is shorter, and radiation dosimetry is similar. Higher cost for 18F NaF may be offset by enhanced patient throughput.

摘要

目的

使用氟 - 18(¹⁸F)氟化钠(¹⁸F NaF)的骨骼正电子发射断层扫描(PET)是锝 - 99m(⁹⁹mTc)亚甲基二膦酸盐(MDP)闪烁扫描的替代方法。儿科PET的经验较少,主要集中在肿瘤学领域。本研究评估¹⁸F NaF在评估背痛年轻患者中的作用。

方法

对94例背痛患者(27例男性,67例女性;平均年龄15岁;范围4 - 26岁)进行了94次¹⁸F NaF PET扫描。在给予¹⁸F NaF(2.1 MBq/kg;最大148 MBq)后30分钟进行三维PET采集。给出了¹⁸F NaF和⁹⁹mTc MDP的辐射剂量。

结果

¹⁸F NaF PET显示55%(52/94)的背痛患者有背痛的可能原因。15例患者有2个或更多潜在的背痛来源。PET诊断为关节突/椎弓根应力(34%)、棘突损伤(16%)、椎体环骨骺损伤(14%)、过渡椎 - 骶关节应力(7%)和骶髂关节炎症/应力(3%)。将¹⁸F NaF PET与⁹⁹mTc MDP闪烁扫描进行比较,注射与扫描之间的时间更短(0.5小时对3小时),辐射剂量测定相似(对于一名55千克患者,¹⁸F NaF和⁹⁹mTc MDP的有效剂量分别为3.5 mGy和2.8 mGy),放射性药物成本更高。

结论

¹⁸F NaF骨PET可以检测背痛年轻患者的各种骨骼异常。相对于⁹⁹mTc MDP,图像分辨率更高。从注射示踪剂到完成检查的总时间更短,辐射剂量测定相似。¹⁸F NaF较高的成本可能因患者通量增加而得到抵消。

相似文献

1
Early experience with fluorine-18 sodium fluoride bone PET in young patients with back pain.18氟氟化钠骨PET在年轻背痛患者中的早期应用经验。
J Pediatr Orthop. 2007 Apr-May;27(3):277-82. doi: 10.1097/BPO.0b013e31803409ba.
2
Skeletal scintigraphy with 18F-NaF PET for the evaluation of bone pain in children.18F-NaF PET 骨骼闪烁显像用于儿童骨痛评估。
AJR Am J Roentgenol. 2011 Sep;197(3):713-9. doi: 10.2214/AJR.11.6670.
3
Technical feasibility, radiation dosimetry and clinical use of F-sodium fluoride (NaF) in evaluation of metastatic bone disease in pediatric population.F - 氟化钠(NaF)在评估儿科人群转移性骨病中的技术可行性、辐射剂量测定及临床应用
Ann Nucl Med. 2018 Nov;32(9):594-601. doi: 10.1007/s12149-018-1279-3. Epub 2018 Jul 17.
4
Pilot prospective evaluation of 99mTc-MDP scintigraphy, 18F NaF PET/CT, 18F FDG PET/CT and whole-body MRI for detection of skeletal metastases.前瞻性评估 99mTc-MDP 闪烁扫描、18F-NaF PET/CT、18F-FDG PET/CT 和全身 MRI 检测骨骼转移的初步研究。
Clin Nucl Med. 2013 Jul;38(7):e290-6. doi: 10.1097/RLU.0b013e3182815f64.
5
The diagnostic and prognostic effectiveness of F-18 sodium fluoride PET-CT in detecting bone metastases for hepatocellular carcinoma patients.F-18 氟化钠PET-CT对肝细胞癌患者骨转移的诊断及预后评估效能
Nucl Med Commun. 2010 Jul;31(7):637-45. doi: 10.1097/MNM.0b013e3283399120.
6
Can we achieve a radionuclide radiation dose equal to or less than that of 99mTc-hydroxymethane diphosphonate bone scintigraphy with a low-dose 18F-sodium fluoride time-of-flight PET of diagnostic quality?我们能否通过具有诊断质量的低剂量18F-氟化钠飞行时间PET实现与99mTc-羟基甲烷二膦酸盐骨闪烁显像相等或更低的放射性核素辐射剂量?
Nucl Med Commun. 2013 May;34(5):417-25. doi: 10.1097/MNM.0b013e32835fcd9d.
7
Novel weight-based dose threshold for 18F-NaF PET-CT imaging using advanced PET-CT systems: a potential tool for reducing radiation burden.使用先进PET-CT系统进行18F-NaF PET-CT成像的基于体重的新型剂量阈值:一种减轻辐射负担的潜在工具。
Nucl Med Commun. 2017 Sep;38(9):764-770. doi: 10.1097/MNM.0000000000000706.
8
Fluorine-18 NaF PET imaging of child abuse.用于虐待儿童的氟-18氟化钠正电子发射断层显像
Pediatr Radiol. 2008 Jul;38(7):776-9. doi: 10.1007/s00247-008-0885-y. Epub 2008 May 27.
9
¹⁸F-fluoride PET and PET/CT in children and young adults.¹⁸F-氟化物PET及PET/CT在儿童和青年中的应用
PET Clin. 2014 Jul;9(3):287-97. doi: 10.1016/j.cpet.2014.03.004.
10
Bone metastases diagnosis possibilities in studies with the use of 18F-NaF and 18F-FDG.使用18F-NaF和18F-FDG的研究中骨转移的诊断可能性
Nucl Med Rev Cent East Eur. 2011;14(2):105-8. doi: 10.5603/nmr.2011.00024.

引用本文的文献

1
The Use of F-Fluoride Positron Emission Tomography/Computed Tomography Scanning to Identify Sources of Pain after Posterior Lumbar Interbody Fusion-An Analysis in Patients with and without Symptoms.使用F-氟化物正电子发射断层扫描/计算机断层扫描来识别腰椎后路椎间融合术后的疼痛来源——有症状和无症状患者的分析
Diagnostics (Basel). 2024 Jun 22;14(13):1327. doi: 10.3390/diagnostics14131327.
2
Application of F-NaF-PET/CT in assessing age-related changes in the cervical spine.F-NaF-PET/CT在评估颈椎年龄相关变化中的应用。
Quant Imaging Med Surg. 2022 Jun;12(6):3314-3324. doi: 10.21037/qims-21-1174.
3
[F] Sodium Fluoride Dose Reduction Enabled by Digital Photon Counting PET/CT for Evaluation of Osteoblastic Activity.
[F] 数字光子计数PET/CT用于评估成骨活性时可降低氟化钠剂量
Front Med (Lausanne). 2022 Jan 12;8:725118. doi: 10.3389/fmed.2021.725118. eCollection 2021.
4
Biodistribution, dosimetry, and temporal signal-to-noise ratio analyses of normal and cancer uptake of [Ga]Ga-P15-041, a gallium-68 labeled bisphosphonate, from first-in-human studies.来自人体首次研究的[镓-68]Ga-P15-041(一种镓-68标记的双膦酸盐)在正常组织和肿瘤摄取中的生物分布、剂量测定及时间信噪比分析。
Nucl Med Biol. 2020 Jul-Aug;86-87:1-8. doi: 10.1016/j.nucmedbio.2020.04.002. Epub 2020 Apr 20.
5
Fusion and Healing Prediction in Posterolateral Spinal Fusion Using F-Sodium Fluoride-PET/CT.使用氟-18 氟化钠正电子发射断层显像/X 线计算机体层成像(F-Sodium Fluoride-PET/CT)预测脊柱后外侧融合术中的融合与愈合情况
Diagnostics (Basel). 2020 Apr 16;10(4):226. doi: 10.3390/diagnostics10040226.
6
Optimization of Radiation Exposure in F-Sodium Fluoride Positron Emission Tomography-Computed Tomography in Bone Imaging: Quo Vadis.F-氟化钠正电子发射断层扫描-计算机断层扫描骨成像中辐射暴露的优化:何去何从。
Indian J Nucl Med. 2019 Apr-Jun;34(2):157-159. doi: 10.4103/ijnm.IJNM_143_18.
7
Gallbladder activity on sodium fluoride positron emission tomography/computed tomography bone scan.氟化钠正电子发射断层扫描/计算机断层扫描骨扫描中的胆囊活性。
World J Nucl Med. 2018 Jul-Sep;17(3):201-203. doi: 10.4103/wjnm.WJNM_45_17.
8
Initial experience with F-sodium fluoride (NaF) PET-CT: a viable functional biomarker in symptomatic Os acromiale.氟代氟化钠(NaF)PET-CT的初步经验:有症状的肩峰骨关节炎中一种可行的功能生物标志物。
Br J Radiol. 2018 Apr;91(1084):20170741. doi: 10.1259/bjr.20170741. Epub 2018 Jan 12.
9
SPECT/CT bone scintigraphy to evaluate low back pain in young athletes: common and uncommon etiologies.单光子发射计算机断层扫描/计算机断层扫描骨闪烁显像评估年轻运动员的腰痛:常见及罕见病因
J Orthop Surg Res. 2016 Jul 7;11(1):76. doi: 10.1186/s13018-016-0402-1.
10
Evolving Role of Molecular Imaging with (18)F-Sodium Fluoride PET as a Biomarker for Calcium Metabolism.分子成像中(18)F-氟化钠正电子发射断层扫描作为钙代谢生物标志物的作用演变
Curr Osteoporos Rep. 2016 Aug;14(4):115-25. doi: 10.1007/s11914-016-0312-5.